Department of Otorhinolaryngology and Laryngological Oncology in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Med Sci Monit. 2021 Sep 18;27:e932004. doi: 10.12659/MSM.932004.
BACKGROUND This retrospective study from a single center in Poland aimed to identify factors associated with outcomes following salvage surgery in 50 patients with recurrent laryngeal cancer. MATERIAL AND METHODS The study group consisted of 50 patients with recurrent laryngeal cancer after primary organ preservation treatment (12 patients after partial surgery, 30 patients after radiation therapy, and 8 patients after prior treatment using both methods). None of the patients received chemotherapy before salvage surgery. All patients with recurrence of laryngeal cancer underwent total laryngectomy with elective bilateral nodal surgery. Local and/or nodal recurrence was considered the failure of primary organ preservation treatment. Efficacy of treatment was assessed in relation to overall survival (OS), disease-free survival (DFS), local control (LC), and locoregional control (LRC). RESULTS Treatment results showed a poor prognosis in patients with local and/or nodal recurrence of laryngeal cancer. In the study group, the updated 5-year rates were as follows: OS rate of 26%; DFS rate of 25%; LC rate of 44%; and LRC rate of 39%. Univariate analysis showed that the stage before primary treatment was a predictive factor of OS (P=0.012). CONCLUSIONS The findings from this retrospective study of 50 patients with recurrent laryngeal carcinoma showed that salvage surgery following organ preservation treatment resulted in a 5-year OS rate of 26%.
本研究回顾性分析了波兰某单一中心的 50 例复发性喉癌患者,旨在明确挽救性手术后结局的相关影响因素。
研究组纳入 50 例经初始器官保留治疗后复发的喉癌患者,其中 12 例接受了部分切除术,30 例接受了放射治疗,8 例接受了上述两种方法的联合治疗。所有患者在挽救性手术前均未接受化疗。所有复发性喉癌患者均接受了全喉切除术及双侧淋巴结选择性清扫术。局部和/或淋巴结复发被认为是初始器官保留治疗失败。治疗效果评估与总生存率(OS)、无病生存率(DFS)、局部控制率(LC)和区域控制率(LRC)相关。
局部和/或淋巴结复发性喉癌患者的治疗结果预后较差。在研究组中,更新后的 5 年生存率分别为:OS 率为 26%;DFS 率为 25%;LC 率为 44%;LRC 率为 39%。单因素分析显示,初始治疗前的分期是 OS 的预测因素(P=0.012)。
本回顾性研究纳入了 50 例复发性喉癌患者,结果显示,挽救性手术治疗后 5 年 OS 率为 26%。